Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men
Loading...
Citations
Web of Science:
Altmetric:
Altmetric::
Download
Associated Records
Authors
File Licence
Editors
Date
2013-06-24
Source Title
Scientific Reports
Journal Title
Journal ISSN
Volume Title
Publisher
NATURE PORTFOLIO
Melbourne Authors
Affiliation
Medicine (RMH)
Medicine (St Vincent's)
Medicine (St Vincent's)
Document Type
Journal Article
Subject Code
Citation
Killick, E., Morgan, R., Launchbury, F., Bancroft, E., Page, E., Castro, E., Kote-Jarai, Z., Aprikian, A., Blanco, I., Clowes, V., Domchek, S., Douglas, F., Eccles, D., Evans, D. G., Harris, M., Kirk, J., Lam, J., Lindeman, G., Mitchell, G. ,... Pandha, H. (2013). Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men. Scientific Reports, 3 (1), https://doi.org/10.1038/srep02059.
Access Status
Open Access
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
Abstract
Controversy surrounds the use of PSA as a biomarker for prostate cancer detection, leaving an unmet need for a novel biomarker in this setting; urinary EN2 may identify individuals with clinically relevant prostate cancer. Male BRCA1 and BRCA2 mutation carriers are at increased risk of clinically significant prostate cancer and may benefit from screening. Urine samples from 413 BRCA1 and BRCA2 mutation carriers and controls were evaluated. Subjects underwent annual PSA screening with diagnostic biopsy triggered by PSA > 3.0 ng/ml; 21 men were diagnosed with prostate cancer. Urinary EN2 levels were measured by ELISA and had a sensitivity of 66.7% and specificity of 89.3% for cancer detection. There was no statistically significant difference in EN2 levels according to genetic status or Gleason score. Urinary EN2 may be useful as a non-invasive early biomarker for prostate cancer detection in genetically high-risk individuals.